Mereo BioPharma (MREO) Total Non-Current Liabilities (2017 - 2026)
Mereo BioPharma (MREO) posted Total Non-Current Liabilities of $5.69 million for Q2 2026, down 28.0% from $7.91 million a year earlier and down 8.2% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Mereo BioPharma's Total Non-Current Liabilities came in at $4.34 million, down 70.3% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -45.7% (FY2020 to FY2025).
- In prior years, Mereo BioPharma's Total Non-Current Liabilities was $14.6 million in FY2024 (-3.9%), $15.2 million in FY2023 (+745.2%), $1.8 million in FY2022 (-94.8%) and $34.88 million in FY2021 (-61.9%).
- Quarterly Total Non-Current Liabilities has run from a low of $1.8 million in Q4 2022 to a high of $160.24 million in Q3 2024 over five years.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last seven quarters, with an average decline of 43.9% over the last seven quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2023, with growth of 745.2%; the weakest was Q3 2025, with a decline of 96.0%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $6.2 million (Q1 2026), $4.34 million (Q4 2025) and $6.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Mereo BioPharma | 47.91 Mn | -79.40 Mn | 800,000.00 | 5.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.46 Mn |
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Sep 30, 2025 | 5.99 Mn |
| Jun 30, 2025 | 7.45 Mn |
| Mar 31, 2025 | 7.39 Mn |
| Dec 31, 2024 | 13.97 Mn |
| Sep 30, 2024 | 159.60 Mn |
| Jun 30, 2024 | 15.96 Mn |
| Mar 31, 2024 | 11.69 Mn |
| Dec 31, 2023 | 14.76 Mn |
| Jun 30, 2023 | 6.86 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Jun 30, 2022 | 3.94 Mn |
| Dec 31, 2021 | 34.93 Mn |
| Jun 30, 2021 | 75.25 Mn |
| Dec 31, 2020 | 94.53 Mn |
| Jun 30, 2020 | 77.77 Mn |
| Dec 31, 2019 | 21.39 Mn |
API Access
Mereo BioPharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();